Boston Partners Long/Short Research Fd Inv Cl Receivables

The latest receivables for BPRRX is $7.4M as of September 2023. That compares with $6.4M in the prior-year period — up 16.1% year over year. Investors often review this figure alongside Boston Partners Long/Short Research Fd Inv Cl's historical trend and sector peers before judging valuation or financial health.

Over the past year, BPRRX's receivables moved from $6.4M to $7.4M — a 16.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Boston Partners Long/Short Research Fd Inv Cl's operating scale or balance-sheet position.

A receivables figure of $7.4M for BPRRX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting BPRRX's receivables ($7.4M), review year-over-year change from $6.4M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.